We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+22.5%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$664M
AUM Growth
-$183M
Cap. Flow
-$289M
Cap. Flow %
-43.52%
Top 10 Hldgs %
55.23%
Holding
79
New
18
Increased
15
Reduced
15
Closed
24

Top Buys

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$22.3M
2
CROX icon
Crocs
CROX
+$15.1M
3
VRT icon
Vertiv
VRT
+$14.1M
4
MOMO
Hello Group
MOMO
+$12.1M
5
FAST icon
Fastenal
FAST
+$9.65M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$30.6M
2
ARMK icon
Aramark
ARMK
+$26.4M
3
BABA icon
Alibaba
BABA
+$22.5M
4
ARGX icon
argenx
ARGX
+$21M
5
MSI icon
Motorola Solutions
MSI
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.87%
2 Consumer Discretionary 13.24%
3 Technology 8.87%
4 Industrials 8.8%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITO
76
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
-398,169
Closed -$2.38M
AGN
77
DELISTED
Allergan plc
AGN
-60,216
Closed -$10.1M
ARQL
78
DELISTED
Arqule Inc
ARQL
-1,171,352
Closed -$13.6M

Similar funds

Kingdon Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Kingdon Capital Management held 79 positions worth $664M, down 22% from $847M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Kingdon Capital Management withdrew a net $289M in Q4 2019, closing 24 positions and reducing 15 holdings. Its most notable exit was Marathon Petroleum, an estimated $30.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Kingdon Capital Management opened a new position in Ally Financial worth $21.8M.

  • Kingdon Capital Management's largest Q4 2019 buy was Ally Financial: 714,040 shares worth $21.8M.
  • Kingdon Capital Management added most to Aerie Pharmaceuticals in Q4 2019, an estimated $8.58M increase.
  • Kingdon Capital Management's biggest Q4 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $20.4M.
  • Kingdon Capital Management fully exited Marathon Petroleum in Q4 2019, selling an estimated $30.6M.
  • Kingdon Capital Management's ten largest holdings make up 55% of its $664M portfolio in Q4 2019.
  • Kingdon Capital Management opened 18 new positions and closed 24 in Q4 2019.
  • Kingdon Capital Management's portfolio value fell 22% quarter-over-quarter to $664M.

Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.